Schedule 13G ownership disclosure
Celldex Therapeutics Inc
Security class unavailable · CUSIP: 15117B202
Event date: 2024-09-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,243,599
- Percent of class
- 13.9400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902219-24-000467
- Form type
- SC 13G
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- Nov 08, 2024
- Reporting period
- Sep 30, 2024
- Description
- Schedule 13G beneficial ownership